Phase II Study of FOLFIRI Plus Bevacizumab (AVASIRI) in Patients as Second Line Chemotherapy of Unresectable Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2616560
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: 5-FU, CPT-11, Bevacizumab
Primary outcome(s): Assessment of overall response rate (ORR; complete response [CR] + partial response [PR]).
Study Design: Single arm Non-randomized
创建时间：
2008-02-15
